Myomo Inc., a company specializing in wearable medical robotics, has released an investor presentation detailing its strategic initiatives and market opportunities. The presentation highlights the company's focus on addressing upper limb paralysis through innovative technology. Key points include securing CMS reimbursement fees to expand access to the Medicare-age population, identifying a sizable market opportunity with a prevalence of up to 600,000 patients, and maintaining a strong competitive position in a growing market. Myomo emphasizes its role as a technology leader with an exciting product development roadmap and outlines its efforts to accelerate the direct billing pipeline and grow its orthotics and prosthetics channel. The company also discusses its attractive margin profile and expanding operating leverage at scale. You can access the full presentation through the link below.